Oxidative stress in the pathogenesis of experimental mesangial proliferative glomerulonephritis

American Journal of Physiology - Renal Physiology

Volumn 285, Issue 6 54-6, 2003, Pages

  Budisavljevic, Milos N ^a,c   Hodge, LeAnn ^a   Barber, Kelli ^a   Fulmer, John R ^a   Durazo Arvizu, Ramon A ^a   Self, Sally E ^b   Kuhlmann, Martin ^d   Raymond, John R ^a,c   Greene, Eddie L ^e  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c RALPH H JOHNSON VA MEDICAL CENTER   (United States)

^d SAARLAND UNIVERSITY   (Germany)

^e MAYO CLINIC   (United States)

Author keywords

Anti Thy 1 nephritis; Extracellular signal regulated kinase; Transforming growth factor 1; lipoic acid; smooth muscle actin

Indexed keywords

ALPHA ACTIN; CYCLINE; MITOGEN ACTIVATED PROTEIN KINASE; REACTIVE OXYGEN METABOLITE; STAT PROTEIN; THIOCTIC ACID; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANTIGEN ANTIBODY COMPLEX; ARTICLE; CELL PROLIFERATION; CELL TRANSFORMATION; EXTRACELLULAR MATRIX; KIDNEY INJURY; MYOFIBROBLAST; NEPHRITIS; NONHUMAN; ONCOGENE C MYC; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROLIFERATIVE GLOMERULONEPHRITIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

EID: 0242581714     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00397.2002     Document Type: Article

References (40)

1. Alpers CE, Hudkins KL, Gown AM, and Johnson RJ. Enhanced expression of "muscle-specific" actin in glomerulonephritis. Kidney Int 41: 1134-1142, 1992.
2. Biewenga GP, Haenen GRMM, and Bast A. The pharmacology of the antioxidant lipoic acid. Gen Pharmacol 29: 315-331, 1997.
3. Bokemeyer D, Guglielmi KE, McGinty A, Sorokin A, Lianos EA, and Dunn MJ. Activation of extracellular signal-regulated kinase in proliferative glomerulonephritis in rats. J Clin Invest 100: 582-588, 1997.
4. Bokemeyer D, Ostendorf T, Kunter U, Lindemann M, Kramer HJ, and Floege J. Differential activation of mitogen-activated protein kinase in experimental mesangioproliferative glomerulonephritis. J Am Soc Nephrol 11: 232-240, 2000.
5. Bokemeyer D, Panek D, Kramer HJ, Lindemann M, Kitahara M, Boor P, Kerjaschki D, Trzaskos JM, Floege J, and Ostendorf T. In vivo identification of the mitogen-activated protein kinase cascade as a central pathogenic pathway in experimental mesangioproliferative glomerulonephritis. J Am Soc Nephrol 13: 1473-1480, 2002.
6. Bokemeyer D, Sorokin A, and Dunn MJ. Multiple intracellular MAP kinase signaling cascades. Kidney Int 49: 1187-1198, 1996.
7. Couser WG and Johnson RJ. Mechanisms of progressive renal disease in glomerulonephritis. Am J Kidney Dis 23: 193-198, 1994.
8. Cowley S, Paterson H, Kemp P, and Marshall CJ. Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells. Cell 77: 841-852, 1994.
9. Gaertner SA, Janssen U, Ostendorf T, Koch KM, Floege J, and Gwinner W. Glomerular oxidative and antioxidative systems in experimental mesangioproliferative glomerulonephritis. J Am Soc Nephrol 13: 2930-2937, 2002.
10. Garrington TP and Johnson GL. Organization and regulation of mitogen-activated protein kinase signaling pathways. Curr Opin Cell Biol 11: 211-218, 1999.
11. Gilbert RE, Kelly DJ, McKay T, Chadban S, Hill PA, Cooper ME, Atkins RC, and Nikolic-Paterson DJ. PDGF signal transduction inhibition ameliorates experimental mesangial proliferative glomerulonephritis. Kidney Int 59: 1324-1332, 2001.
12. 2 generation in rat renal mesangial cells. Am J Physiol Renal Physiol 278: F650-F658, 2000.
13. 2A receptor induces TGF-β1 expression in mesangial cells via ERK: proliferative and fibrotic signals. Am J Physiol Renal Physiol 276: F922-F930, 1999.
14. Gwinner W and Groene HJ. Role of reactive oxygen species in glomerulonephritis. Nephrol Dial Transplant 15: 1127-1132, 2000.
15. Kip1. J Am Soc Nephrol 11: 1387-1397, 2000.
16. Iida H, Seifert R, Alpers CE, Gronwald RGK, Phillips PE, Pritzl P, Gordon K, Gown AM, Ross R, Bowen-Pope DF, and Johnson RJ. Platelet-derived growth factor (PDGF) and PDGF receptor are induced in mesangial proliferative nephritis in rat. Proc Natl Acad Sci USA 88: 6560-6564, 1991.
17. Johnson RJ. The glomerular response to injury: progression or resolution. Kidney Int 45: 1769-1782, 1994.
18. Johnson RJ, Lovett D, Lehrer RI, Couser WG, and Klebanoff SJ. Role of oxidants and proteases in glomerular injury. Kidney Int 45: 352-359, 1994.
19. Kitamura M. The antioxidant N-acetylcysteine induces mesangial cells to create three-dimensional cytoarchitecture that underlies cellular differentiation. J Am Soc Nephrol 10: 746-751, 1999.
20. Kitamura M and Fine LG. The concept of glomerular selfdefense. Kidney Int 55: 1639-1671, 1999.
21. Mansour SJ, Matten WT, Hermann AS, Candia JM, Rong S, Fukasawa K, Vande Woude GF, and Ahn NG. Transformation of mammalian cells by constitutively active MAP kinase kinase. Science 265: 966-970, 1994.
22. Matsumoto T, Yokote K, Tamura K, Takemoto M, Ueno H, Saito Y, and Mori S. Platelet-derived growth factor activates p38 mitogen-activated protein kinase through a Ras-dependent pathway that is important for actin reorganization and cell migration. J Biol Chem 274: 13954-13960, 1999.
23. Melhem MF, Craven PA, Liachenko J, and Derubertis FR. α-Lipoic acid attenuates hyperglycemia and prevents glomerular mesangial matrix expansion in diabetes. J Am Soc Nephrol 13: 108-116, 2002.
24. Nakamura K, Oka M, Shirai M, Igarashi Y, Kojima K, Kaneko O, Hamada N, Mera J, Masaoka H, and Nagase M. Source of reactive oxygen species in anti-Thy 1 nephritis. Ren Fail 20: 399-405, 1998.
25. Nath KA, Croatt AJ, and Hostetter TH. Oxygen consumption and oxidant stress in surviving nephrons. Am J Physiol Renal Fluid Electrolyte Physiol 258: F1354-F1362, 1990.
26. Nath KA, Fischereder M, and Hostetter TH. The role of oxidants in progressive renal injury. Kidney Int 45: S111-S115, 1994.
27. Ohara Y, Peterson TE, and Harrison DG. Hypercholesterolemia increases endothelial superoxide anion production. J Clin Invest 91: 2546-2551, 1993.
28. Oka H, Chatani Y, Hoshino R, Ogawa O, Kakehi Y, Terachi T, Okada Y, Kawaichi M, Kohno M, and Yoshida O. Constitutive activation of mitogen-activated protein (MAP) kinases in human renal cell carcinoma. Cancer Res 55: 4182-4187, 1995.
29. Packer L. α-Lipoic acid: a metabolic antioxidant which regulates NF-κB signal transduction and protects against oxidative injury. Drug Metab Rev 30: 245-275, 1998.
30. Packer L, Witt EH, and Tritschler HJ. α-Lipoic acid as a biological antioxidant. Free Radic Biol Med 19: 227-250, 1995.
31. Paul RV, Wackym PS, and Budisavljevic MN. Destabilization of natriuretic peptide C-receptor mRNA by phorbol myristate acetate. J Am Soc Nephrol 9: 26-32, 1998.
32. Poss KD and Tonegawa S. Heme oxygenase 1 is required for mammalian iron reutilization. Proc Natl Acad Sci USA 94: 10919-10924, 1997.
33. Rohrmoser MM and Mayer G. Reactive oxygen species and glomerular injury. Kidney Blood Press Res 19: 263-269, 1996.
34. Schaeffer HJ, Catling AD, Eblen ST, Collier LS, Krauss A, and Weber MJ. MP1: a MEK binding partner that enhances enzymatic activation of the MAP kinase cascade. Science 281: 1668-1671, 1998.
35. Schocklmann HO, Lang S, and Sterzel RB. Regulation of mesangial cell proliferation. Kidney Int 56: 1199-1207, 1999.
36. Shah SV. The role of reactive oxygen metabolites in glomerular disease. Annu Rev Physiol 57: 245-262, 1995.
37. Suzuki YS, Forman HJ, and Sevanian A. Oxidants as stimulators of signal transduction. Free Radic Biol Med 22: 269-285, 1997.
38. Utsunomiya Y, Kawamura T, Abe A, Imai H, Hirano K, Maruyama N, Hosoya T, and Sakai O. Significance of mesangial expression of α-smooth muscle actin in the progression of IgA nephropathy. Am J Kidney Dis 34: 902-910, 1999.
39. Wada J, Shikata K, and Makino H. Novel approaches to unravel the genesis of glomerulosclerosis by new methodologies in molecular biology and molecular genetics. Nephrol Dial Transplant 14: 2551-2553, 1999.
40. Widmann C, Gibson S, Jarpe MB, and Johnson GL. Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human. Physiol Rev 79: 143-180, 1999.